Summary
Updated Aug 31, 2026
Junli He is CEO, Director of Harvard Apparatus Regenerative Technology, Inc. (HRGN). 5 SEC Form 4 filings on record going back to 2025, most recently on 11 August 2026. Most recent open-market trade: bought $5K of HRGN on 1 December 2025. Lifetime open-market purchases: $33K. Historical track record: 5/5 stars across 4 tracked purchases.
Recent Transactions
4Every recent SEC Form 4 transaction Junli He has reported, most recent first.
$HRGN Harvard Apparatus Regenerative Technology, Inc.P - Open-market purchase11.2K shares @ $1.85$21K
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★★ (5/5) |
| Total purchases tracked | 4 |
| Purchases with forward-return data | 4 |
| 30-day win rate | 100% |
| 90-day win rate | 50% |
| Avg 5-day return | -0.35% |
| Avg 30-day return | +10.88% |
| Avg 90-day return | -1.16% |
| Best 30-day return | +19.88% |
Trading Pattern
InsiderAlpha's records for Junli He go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. The typical open-market purchase is $8K (4 buys totaling $33K). The largest single buy on record is $21K of HRGN in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Junli He's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- QVT Financial LP - $147.38M of ROIV open-market activity in the last 12 months
- Daniel Allen Gold - $147.38M of ROIV open-market activity in the last 12 months
- ULSE Inc. - $146.25M of ULS open-market activity in the last 12 months
- Fairmount Funds Management LLC - $133.53M of APGE open-market activity in the last 12 months
- Jason P. Rhodes - $124.92M of DYN open-market activity in the last 12 months
- Stephen M. Bloch - $118.66M of LQDA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Junli He?
Junli He is a corporate insider, tracked as CEO, Director of Harvard Apparatus Regenerative Technology, Inc. (HRGN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Junli He submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Junli He been buying or selling stock?
Recorded transactions: 4 open-market purchases ($33K) and 0 open-market sales across all tracked filings.
How accurate is Junli He's historical track record?
Across 4 tracked purchases, Junli He averaged +10.9% avg 30-day return with a 100% 30-day win rate. InsiderAlpha rates the track record at 5/5 stars.
Where can I see all of Junli He's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Junli He and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial